Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial

Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial ORIGINAL ARTICLE Four-Year Results of Low-Dose CT Screening and Nodule  Management in the ITALUNG Trial Andrea Lopes Pegna, MD* Giulia Picozzi, MD,† Fabio Falaschi, MD,‡ Laura Carrozzi, MD,§ Massimo Falchini, MD,║ Francesca Maria Carozzi, MD,¶ Francesco Pistelli, MD, § Camilla Comin, MD,# Annalisa Deliperi, MD,‡ Michela Grazzini, MD,** Florio Innocenti, MD,** Cristina Maddau, MD,¶ Alessandra Vella, MD, PhD,†† Luca Vaggelli, MD,║║ Eugenio Paci, MD, PhD,¶¶ and Mario Mascalchi, MD, PhD║ for the ITALUNG Study Research Group LDCT screening and management protocol in the active arm of the Introduction: Recruitment and nodule management are critical ITALUNG trial. issues of lung cancer screening with low-dose computed tomog- Methods: Three thousand two hundred six smokers or former smok- raphy (LDCT). We report subjects’ compliance and results of ers invited by mail were randomized to receive four annual LDCT (n = 1613) or usual care (n = 1593). Management protocol included *Pneumonology Department, Careggi Hospital, Florence, Italy; †Radiodiagnostic Unit, 18 follow-up LDCT, 2-[ F]fluoro-2-deoxy-D glucose positron emis- Institute for Oncological Study and Prevention, Florence, Italy; ‡2nd Radiology sion tomography (FDG-PET), and CT-guided fine-needle aspiration Department, University Hospital of Pisa, Italy; §Cardiopulmonary Department, biopsy (FNAB). University Hospital, Pisa, Italy; ║Radiodiagnostic Section, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy; Results: One thousand http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial

Journal of Thoracic Oncology , Volume 8 (7) – Jul 1, 2013

Loading next page...
 
/lp/wolters-kluwer-health/four-year-results-of-low-dose-ct-screening-and-nodule-management-in-Pl2Y0VLMlS

References (81)

Copyright
Copyright © 2013 by the International Association for the Study of Lung Cancer
ISSN
1556-0864
DOI
10.1097/JTO.0b013e31828f68d6
pmid
23612465
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Four-Year Results of Low-Dose CT Screening and Nodule  Management in the ITALUNG Trial Andrea Lopes Pegna, MD* Giulia Picozzi, MD,† Fabio Falaschi, MD,‡ Laura Carrozzi, MD,§ Massimo Falchini, MD,║ Francesca Maria Carozzi, MD,¶ Francesco Pistelli, MD, § Camilla Comin, MD,# Annalisa Deliperi, MD,‡ Michela Grazzini, MD,** Florio Innocenti, MD,** Cristina Maddau, MD,¶ Alessandra Vella, MD, PhD,†† Luca Vaggelli, MD,║║ Eugenio Paci, MD, PhD,¶¶ and Mario Mascalchi, MD, PhD║ for the ITALUNG Study Research Group LDCT screening and management protocol in the active arm of the Introduction: Recruitment and nodule management are critical ITALUNG trial. issues of lung cancer screening with low-dose computed tomog- Methods: Three thousand two hundred six smokers or former smok- raphy (LDCT). We report subjects’ compliance and results of ers invited by mail were randomized to receive four annual LDCT (n = 1613) or usual care (n = 1593). Management protocol included *Pneumonology Department, Careggi Hospital, Florence, Italy; †Radiodiagnostic Unit, 18 follow-up LDCT, 2-[ F]fluoro-2-deoxy-D glucose positron emis- Institute for Oncological Study and Prevention, Florence, Italy; ‡2nd Radiology sion tomography (FDG-PET), and CT-guided fine-needle aspiration Department, University Hospital of Pisa, Italy; §Cardiopulmonary Department, biopsy (FNAB). University Hospital, Pisa, Italy; ║Radiodiagnostic Section, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy; Results: One thousand

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Jul 1, 2013

There are no references for this article.